These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22402445)
1. Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. Leslie Pedrioli DM; Fu DJ; Gonzalez-Gonzalez E; Contag CH; Kaspar RL; Smith FJ; McLean WH J Invest Dermatol; 2012 Jun; 132(6):1627-35. PubMed ID: 22402445 [TBL] [Abstract][Full Text] [Related]
2. Targeting the palm: a leap forward toward treatment of keratin disorders. Roth W; Hatzfeld M; Magin TM J Invest Dermatol; 2012 Jun; 132(6):1541-2. PubMed ID: 22584502 [TBL] [Abstract][Full Text] [Related]
3. Six generations of epidermolytic palmoplantar keratoderma, associated with a KRT9 R163W mutation. Wang P; Kang XJ; Tang XH; Liu JY; Li WZ; Wang WJ; Liang SN; Feng YY; Ding Y; Chen WJ Cancer Genet; 2016 Nov; 209(11):515-524. PubMed ID: 27864007 [TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel Keratin 9 Missense Mutation in a Chinese Family with Epidermolytic Palmoplantar Keratoderma. Xiao H; Guo Y; Yi J; Xia H; Xu H; Yuan L; Hu P; Yang Z; He Z; Lu H; Deng H Cell Physiol Biochem; 2018; 46(5):1919-1929. PubMed ID: 29719290 [TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders. Li P; Qi J; Zhong Y; Ding A; Xiao H J Proteomics; 2023 Sep; 287():104971. PubMed ID: 37467889 [TBL] [Abstract][Full Text] [Related]
6. Possible anticipation in familial epidermolytic palmoplantar keratoderma with the p.R163W mutation of Keratin 9. Guo Y; Shi M; Tan ZP; Shi XL Genet Mol Res; 2014 Oct; 13(4):8089-93. PubMed ID: 25299193 [TBL] [Abstract][Full Text] [Related]
7. Keratin 9 is required for the structural integrity and terminal differentiation of the palmoplantar epidermis. Fu DJ; Thomson C; Lunny DP; Dopping-Hepenstal PJ; McGrath JA; Smith FJD; Irwin McLean WH; Leslie Pedrioli DM J Invest Dermatol; 2014 Mar; 134(3):754-763. PubMed ID: 23962810 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the KRT9 gene in a Mexican family with epidermolytic palmoplantar keratoderma. Lopez-Valdez J; Rivera-Vega MR; Gonzalez-Huerta LM; Cazarin J; Cuevas-Covarrubias S Pediatr Dermatol; 2013; 30(3):354-8. PubMed ID: 23278372 [TBL] [Abstract][Full Text] [Related]
9. KRT9 gene mutation as a reliable indicator in the prenatal molecular diagnosis of epidermolytic palmoplantar keratoderma. Ke HP; Jiang HL; Lv YS; Huang YZ; Liu RR; Chen XL; Du ZF; Luo YQ; Xu CM; Fan QH; Zhang XN Gene; 2014 Aug; 546(1):124-8. PubMed ID: 24862219 [TBL] [Abstract][Full Text] [Related]
10. A Small Indel Mutant Mouse Model of Epidermolytic Palmoplantar Keratoderma and Its Application to Mutant-specific shRNA Therapy. Lyu YS; Shi PL; Chen XL; Tang YX; Wang YF; Liu RR; Luan XR; Fang Y; Mei RH; Du ZF; Ke HP; Matro E; Li LE; Lin ZY; Zhao J; Gao X; Zhang XN Mol Ther Nucleic Acids; 2016 Mar; 5(3):e299. PubMed ID: 27003758 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the keratin 9 gene in Pakistani families with epidermolytic palmoplantar keratoderma. Shimomura Y; Wajid M; Weiser J; Kraemer L; Christiano AM Clin Exp Dermatol; 2010 Oct; 35(7):759-64. PubMed ID: 19874353 [TBL] [Abstract][Full Text] [Related]
12. [Pathological features and gene mutation analysis in two pedigrees of diffuse palmoplantar keratoderma]. Yin XZ; Zhang BR; Ding MP; Zhang H; Xia K; Hu ZM Yi Chuan; 2007 Mar; 29(3):301-5. PubMed ID: 17369150 [TBL] [Abstract][Full Text] [Related]
14. Epidermolytic palmoplantar keratoderma caused by activation of a cryptic splice site in KRT9. Fuchs-Telem D; Padalon-Brauch G; Sarig O; Sprecher E Clin Exp Dermatol; 2013 Mar; 38(2):189-92: quiz 192. PubMed ID: 23397986 [TBL] [Abstract][Full Text] [Related]
15. [Mutation analysis of keratin 9 gene in a family with epidermolytic palmoplantar keratoderma]. Li YL; Li NN; Wang YP; Li MR; Dai L; Deng Y; Liu Z; Mu DZ; Zhu J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):280-3. PubMed ID: 22678789 [TBL] [Abstract][Full Text] [Related]
16. Identification of the keratin 9 (KRT9) N161S mutation in a Chinese kindred with epidermolytic palmoplantar keratoderma. Feng W; Han W; Man X; Jiang M; Bian C; Wang G; Li X; Yi D; Li J Eur J Dermatol; 2008; 18(4):387-90. PubMed ID: 18573708 [TBL] [Abstract][Full Text] [Related]
17. The most common mutation of KRT9, c.C487T (p.R163W), in epidermolytic palmoplantar keratoderma in two large Chinese pedigrees. Liu WT; Ke HP; Zhao Y; Chen XL; Lu JJ; Du ZF; Yu D; Zhang XN Anat Rec (Hoboken); 2012 Apr; 295(4):604-9. PubMed ID: 22262370 [TBL] [Abstract][Full Text] [Related]
18. Keratin-9 gene mutation in epidermolytic palmoplantar keratoderma combined with knuckle pads in a large Chinese family. Li M; Yang LJ; Hua HK; Zhu XH; Dai XY Clin Exp Dermatol; 2009 Jan; 34(1):26-8. PubMed ID: 17362238 [TBL] [Abstract][Full Text] [Related]
19. Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review. Liu X; Qiu C; He R; Zhang Y; Zhao Y Mol Genet Genomic Med; 2019 Nov; 7(11):e977. PubMed ID: 31525823 [TBL] [Abstract][Full Text] [Related]
20. A novel mutation of KRT9 gene in a Chinese Han pedigree with epidermolytic palmoplantar keratoderma. Chen N; Sun J; Song Y; Wei X; Shi Y; Zhang L J Cosmet Dermatol; 2017 Sep; 16(3):402-406. PubMed ID: 27726289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]